NASDAQ
Dermata Therapeutics, Inc. (DRMA) has a fcf yield of -361024.00% as of Friday, May 29, 2026. This represents a 157355.79% decrease compared to its 12-month average of -229.29%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.